BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10889529)

  • 41. Serotonin transporter gene not associated with psychotic symptomatology of mood disorders.
    Serretti A; Lattuada E; Catalano M; Smeraldi E
    Psychiatry Res; 1999 Apr; 86(1):59-65. PubMed ID: 10359482
    [TBL] [Abstract][Full Text] [Related]  

  • 42. No evidence of linkage between schizophrenia and D2 dopamine receptor gene locus in Italian pedigrees.
    Grassi E; Mortilla M; Amaducci L; Pallanti S; Pazzagli A; Galassi F; Guarnieri BM; Petruzzi C; Bolino F; Ortenzi L; Nistico R; De Cataldo S; Rossi A; Sorbi S
    Neurosci Lett; 1996 Mar; 206(2-3):196-8. PubMed ID: 8710185
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A family study of psychotic symptomatology in schizophrenia, schizoaffective disorder, unipolar depression, and bipolar disorder.
    Winokur G; Scharfetter C; Angst J
    Eur Arch Psychiatry Neurol Sci; 1985; 234(5):295-8. PubMed ID: 3987737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A controlled family study of chronic psychoses. Schizophrenia and schizoaffective disorder.
    Gershon ES; DeLisi LE; Hamovit J; Nurnberger JI; Maxwell ME; Schreiber J; Dauphinais D; Dingman CW; Guroff JJ
    Arch Gen Psychiatry; 1988 Apr; 45(4):328-36. PubMed ID: 3355320
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression and characterization of a dopamine D4R variant associated with delusional disorder.
    Zenner MT; Nobile M; Henningsen R; Smeraldi E; Civelli O; Hartman DS; Catalano M
    FEBS Lett; 1998 Jan; 422(2):146-50. PubMed ID: 9489994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The ALDH2 and DRD2/ANKK1 genes interacted in bipolar II but not bipolar I disorder.
    Lee SY; Chen SL; Chang YH; Chen SH; Chu CH; Huang SY; Tzeng NS; Wang CL; Lee IH; Yeh TL; Yang YK; Lu RB
    Pharmacogenet Genomics; 2010 Aug; 20(8):500-6. PubMed ID: 20577142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serotonin transporter gene is not associated with symptomatology of schizophrenia.
    Serretti A; Catalano M; Smeraldi E
    Schizophr Res; 1999 Jan; 35(1):33-9. PubMed ID: 9988839
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factor analysis of delusional disorder symptomatology.
    Serretti A; Lattuada E; Cusin C; Smeraldi E
    Compr Psychiatry; 1999; 40(2):143-7. PubMed ID: 10080261
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Symptomatologic analysis of psychotic and non-psychotic depression.
    Lattuada E; Serretti A; Cusin C; Gasperini M; Smeraldi E
    J Affect Disord; 1999 Jul; 54(1-2):183-7. PubMed ID: 10403162
    [TBL] [Abstract][Full Text] [Related]  

  • 50. No evidence of linkage between the dopamine D2 receptor gene and schizophrenia.
    Hallmayer J; Maier W; Schwab S; Ertl MA; Minges J; Ackenheil M; Lichtermann D; Wildenauer DB
    Psychiatry Res; 1994 Aug; 53(2):203-15. PubMed ID: 7824680
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association between dopaminergic polymorphisms and borderline personality traits among at-risk young adults and psychiatric inpatients.
    Nemoda Z; Lyons-Ruth K; Szekely A; Bertha E; Faludi G; Sasvari-Szekely M
    Behav Brain Funct; 2010 Jan; 6():4. PubMed ID: 20205808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: Ser311Cys polymorphisms of the dopamine D2-receptor gene and schizophrenia.
    Itokawa M; Arinami T; Toru M
    J Pharmacol Sci; 2010; 114(1):1-5. PubMed ID: 20716857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of DRD2 gene variant with schizophrenia.
    Kukreti R; Tripathi S; Bhatnagar P; Gupta S; Chauhan C; Kubendran S; Janardhan Reddy YC; Jain S; Brahmachari SK
    Neurosci Lett; 2006 Jan; 392(1-2):68-71. PubMed ID: 16183199
    [TBL] [Abstract][Full Text] [Related]  

  • 54. No association of the structural dopamine D2 receptor (DRD2) variant 311Cys with alcoholism.
    Finckh U; von Widdern O; Giraldo-Velasquez M; Podschus J; Dufeu P; Sander T; Harms H; Schmidt LG; Rommelspacher H; Rolfs A
    Alcohol Clin Exp Res; 1996 May; 20(3):528-32. PubMed ID: 8727249
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preliminary evidence that negative symptom severity relates to multilocus genetic profile for dopamine signaling capacity and D2 receptor binding in healthy controls and in schizophrenia.
    Eisenstein SA; Bogdan R; Chen L; Moerlein SM; Black KJ; Perlmutter JS; Hershey T; Barch DM
    J Psychiatr Res; 2017 Mar; 86():9-17. PubMed ID: 27886638
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.
    Sáiz PA; García-Portilla MP; Arango C; Morales B; Arias B; Corcoran P; Fernández JM; Alvarez V; Coto E; Bascarán MT; Bousoño M; Fañanas L; Bobes J
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):26-31. PubMed ID: 19766158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Linkage of mood disorders with D2, D3 and TH genes: a multicenter study.
    Serretti A; Macciardi F; Cusin C; Lattuada E; Souery D; Lipp O; Mahieu B; Van Broeckhoven C; Blackwood D; Muir W; Aschauer HN; Heiden AM; Ackenheil M; Fuchshuber S; Raeymaekers P; Verheyen G; Kaneva R; Jablensky A; Papadimitriou GN; Dikeos DG; Stefanis CN; Smeraldi E; Mendlewicz J
    J Affect Disord; 2000 Apr; 58(1):51-61. PubMed ID: 10760558
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Study of HL-A antigens in endogenous psychoses].
    Morasiewicz J
    Psychiatr Pol; 1979; 13(5):511-7. PubMed ID: 390589
    [No Abstract]   [Full Text] [Related]  

  • 59. No association of dopamine D2 receptor molecular variant Cys311 and schizophrenia in Chinese patients.
    Chen CH; Chien SH; Hwu HG
    Am J Med Genet; 1996 Jul; 67(4):418-20. PubMed ID: 8837714
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis.
    Ujike H; Katsu T; Okahisa Y; Takaki M; Kodama M; Inada T; Uchimura N; Yamada M; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):625-9. PubMed ID: 19275926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.